GOLDMAN SACHS GROUP INC - ASTRIA THERAPEUTICS INC ownership

ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 35 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ASTRIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$212,833
-0.3%
28,530
+11.3%
0.00%
Q2 2023$213,523
-77.8%
25,633
-64.5%
0.00%
Q1 2023$959,688
+869.4%
72,157
+543.1%
0.00%
Q3 2021$99,00011,2210.00%
Other shareholders
ASTRIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Altium Capital Management LP 1,347,088$17,916,2709.94%
Fairmount Funds Management LLC 1,901,397$25,288,5804.35%
Ikarian Capital, LLC 869,390$11,562,8872.62%
Affinity Asset Advisors, LLC 529,369$7,040,6082.32%
Logos Global Management LP 1,044,960$13,897,9681.99%
Ghost Tree Capital, LLC 450,000$5,985,0001.77%
Vivo Capital, LLC 1,681,199$22,359,9471.55%
Opaleye Management Inc. 302,000$4,096,4001.23%
Tri Locum Partners LP 275,011$3,657,6461.11%
Saturn V Capital Management LP 101,339$1,347,8091.01%
View complete list of ASTRIA THERAPEUTICS INC shareholders